MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

NVP-BSK805 trihydrochloride

CAS No. : 2320258-95-3

MCE 站：NVP-BSK805 trihydrochloride

产品活性：NVP-BSK805 trihydrochloride 是一种 ATP 竞争性的 JAK2 抑制剂，对 JAK2 JH1 (JAK 同源 1)，JAK1 JH1，JAK3 JH1，和 TYK2 JH1 的 IC₅₀ 值分别为 0.48 nM，31.63 nM，18.68 nM 和 10.76 nM。

研究领域：Epigenetics  |  Stem Cell/Wnt  |  JAK/STAT Signaling

作用靶点：JAK

In Vitro: NVP-BSK805 trihydrochloride (BSK 805) is a JAK2 inhibitor, with IC₅₀s of 0.48 nM, 31.63 nM, 18.68 nM, ａnd 10.76 nM for JAK2 JH1 (JAK homology 1), JAK1 JH1, JAK3 JH1, ａnd TYK2 JH1, respectively. NVP-BSK805 trihydrochloride inhibits the full-length wild-type JAK2 (FL JAK2 wt) ａnd FL JAK2 V617F activity, with IC₅₀s of 0.58 ± 0.03 ａnd 0.56 ± 0.04 nM. NVP-BSK805 trihydrochloride is ATP-competitive, with aclculated K_i of 0.43 ± 0.02 nM. NVP-BSK805 trihydrochloride suppresses the growth of JAK2^V617F-bearing acute myeloid leukemia cell lines with GI₅₀ of <100 nM. NVP-BSK805 trihydrochloride blocks the STAT5 phosphorylation at ≥100 nM concentrations, ａnd shows a bias for JAK2 over JAK1 ａnd JAK3 inhibition in the JAK2^V617F-mutant cell lines.
NVP-BSK805 trihydrochloride (5 μM) improves P-gp inhibitory activity. NVP-BSK805 trihydrochloride increases sensitization of drug-resistant KBV20C cancer cells to VIC treatment at 10 μM, ａnd such an effect is more effective than a 5 μM dose.

In Vivo: NVP-BSK805 trihydrochloride (BSK 805; 150 mg/kg, p.o.) blocks STAT5 phosphorylation, splenomegaly, ａnd leukemic cell spreading in a Ba/F3 JAK2^V617F cell-driven mouse model.
NVP-BSK805 trihydrochloride (50, 75, ａnd 100 mg/kg, p.o.) also suppresses rhEpo-mediated polycythemia ａnd splenomegaly in BALB/c mice.

相关产品：AG490  |  Upadacitinib  |  AT9283  |  Gandotinib  |  Lestaurtinib  |  Oclacitinib maleate  |  JANEX-1  |  Cucurbitacin I  |  XL019  |  Atractylenolide I  |  FLLL32  |  LFM-A13  |  Brevilin A  |  ZM39923 hydrochloride  |  Ginsenoside Rk1  |  WHI-P154  |  Curculigoside  |  FM-381  |  RO8191  |  Reticuline  |  Ilginatinib maleate  |  TCS 21311  |  WHI-P97  |  Protosappanin A  |  Coumermycin A1  |  Dehydrocrenatidine  |  Delphinidin chloride  |  FM-479  |  NSC 33994

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。